New Dermal Filler for Chin Correction and Augmentation

Galderma

Status: Completed

Conditions: Chin Augmentation and Correction

Treatments: Device: Hyaluronic Acid

Study type: Interventional

Funder types: Industry

Identifiers

NCT04631263

43BBJ2001

Details and patient eligibility

About

Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada

Enrollment: 140 patients

Sex: All

Ages: 19+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• subject willing to comply with the requirements of the study
• subject intent to receive treatment for augmentation and correction of retrusion in the chin region
• subject with mild or moderate (grade 1 or 2) on the GCRS

Exclusion criteria

• subjects presenting with know allergy to HA (hyaluronic acid) filler or amide local anesthetics
• subjects with any previous facial surgery below the nasal line or previous HA filler or collagen below the nasal line within 12 months
• subjects in any other interventional clinical study within 30 days before baseline

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

140 participants in 2 patient groups

Treatment Group

Experimental group

Treatment:

Device: Hyaluronic Acid

Control Group

No Intervention group